Evidence map›Paper›PMID 27756356›Full record

ArticleJournal of medical case reports2016

Oral mucosal melanoma treated with carbon ion radiotherapy: a case report.

Atsushi Musha, Jun-Ichi Saitoh, Katsuyuki Shirai, Satoshi Yokoo, Tatsuya Ohno, Takashi Nakano

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Mucosal Melanoma of the Hard Palate: Surgical Treatment and Reconstruction.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Atsushi MushaGunma University Heavy Ion Medical Center, 3-39-22 Showa-machi, Maebashi, Gunma, Japan. musha@gunma-u.ac.jp.
Jun-Ichi SaitohGunma University Heavy Ion Medical Center, 3-39-22 Showa-machi, Maebashi, Gunma, Japan.
Katsuyuki ShiraiGunma University Heavy Ion Medical Center, 3-39-22 Showa-machi, Maebashi, Gunma, Japan.
Satoshi YokooDepartment of Stomatology and Maxillofacial Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, Japan.
Tatsuya OhnoGunma University Heavy Ion Medical Center, 3-39-22 Showa-machi, Maebashi, Gunma, Japan.
Takashi NakanoGunma University Heavy Ion Medical Center, 3-39-22 Showa-machi, Maebashi, Gunma, Japan.
Gunma University Hospital · JPGunma University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral mucosal melanoma is a rare disease with a relatively poor prognosis. Carbon ion radiotherapy has been shown to be effective against radiotherapy-resistant tumors owing to its excellent dose concentration and high biological effect. CASE PRESENTATION: Our patient was a 66-year-old Japanese man with oral mucosal melanoma of his right maxillary gingiva (T4aN0M0). He received carbon ion radiotherapy at 57.6 Gy (relative biological effectiveness) in 16 fractions for 4 weeks. Concomitant chemotherapy (dacarbazine + nimustine + vincristine) was administered at the same time as carbon ion radiotherapy initiation. Two courses of adjuvant chemotherapy were given after carbon ion radiotherapy. Although he experienced grade 2 acute oral mucositis, his symptoms improved within a few weeks of undergoing carbon ion radiotherapy. He was alive at the time of reporting, 35 months after treatment, without any recurrence. Late toxicity has not been observed.

conclusionsCarbon ion radiotherapy for oral mucosal melanoma resulted in a good local effect.

Indexed as

Heavy Ion RadiotherapyAgedAntineoplastic Agents, PhytogenicCombined Modality TherapyDacarbazineHumansMaleMelanomaMouth MucosaMouth NeoplasmsMucous MembraneNeoplasm Recurrence, LocalNimustineRadiation InjuriesRadiotherapy DosageTreatment OutcomeAntineoplastic Agents, PhytogenicDacarbazineNimustineVincristineCarbon ion radiotherapyConcomitant chemotherapyHead and neck tumorOral mucosal melanoma

Identifiers

PMID27756356
PMCPMC5070148
OpenAlexW2538069360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.